{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:53:33Z","timestamp":1789588413292,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,2,24]]},"DOI":"10.1038\/s41388-025-03674-9","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T21:09:26Z","timestamp":1769634566000},"page":"690-702","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Matrix stiffness-driven cytoskeletal remodeling and tumor progression in anaplastic thyroid cancer via integrin-focal adhesion kinase signaling"],"prefix":"10.1038","volume":"45","author":[{"given":"Chenyao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianxue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8805-065X","authenticated-orcid":false,"given":"Guang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"key":"3674_CR1","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.3390\/cancers14041061","volume":"14","author":"A Jannin","year":"2022","unstructured":"Jannin A, Escande A, Al Ghuzlan A, Blanchard P, Hartl D, Chevalier B, et al. Anaplastic Thyroid Carcinoma: An Update. Cancers. 2022;14:1061.","journal-title":"Cancers"},{"key":"3674_CR2","unstructured":"Menon G, Kashyap S, Naing PT, Mathias PM, Giwa AO Anaplastic Thyroid Cancer. In: StatPearls. StatPearls Publishing: Treasure Island (FL), 2024."},{"key":"3674_CR3","doi-asserted-by":"publisher","unstructured":"Gao X, Hong C, Xie Y, Zeng X Immunotherapy or targeted therapy: What will be the future treatment for anaplastic thyroid carcinoma? Front Oncol. 2023; 13. https:\/\/doi.org\/10.3389\/fonc.2023.1103147.","DOI":"10.3389\/fonc.2023.1103147"},{"key":"3674_CR4","doi-asserted-by":"publisher","unstructured":"Xia J, Shi Y, Chen X New insights into the mechanisms of the extracellular matrix and its therapeutic potential in anaplastic thyroid carcinoma. Sci Rep. 2024; 14. https:\/\/doi.org\/10.1038\/s41598-024-72020-y.","DOI":"10.1038\/s41598-024-72020-y"},{"key":"3674_CR5","doi-asserted-by":"publisher","unstructured":"Saini S, Tulla K, Maker AV, Burman KD, Prabhakar BS Therapeutic advances in anaplastic thyroid cancer: a current perspective. Mol Cancer. 2018; 17. https:\/\/doi.org\/10.1186\/s12943-018-0903-0.","DOI":"10.1186\/s12943-018-0903-0"},{"key":"3674_CR6","doi-asserted-by":"publisher","unstructured":"Alhejaily A-M, Alhuzim O, Alwelaie Y Anaplastic thyroid cancer: Pathogenesis, prognostic factors and genetic landscape (Review). Mol Clin Oncol. 2023; 19. https:\/\/doi.org\/10.3892\/mco.2023.2695.","DOI":"10.3892\/mco.2023.2695"},{"key":"3674_CR7","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/cac2.12416","volume":"43","author":"A Goenka","year":"2023","unstructured":"Goenka A, Khan F, Verma B, Sinha P, Dmello CC, Jogalekar MP, et al. Tumor microenvironment signaling and therapeutics in cancer progression. Cancer Commun. 2023;43:525\u201361.","journal-title":"Cancer Commun"},{"key":"3674_CR8","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.semcancer.2021.09.003","volume":"85","author":"S Mukhopadhyay","year":"2022","unstructured":"Mukhopadhyay S, Mahapatra KK, Praharaj PP, Patil S, Bhutia SK. Recent progress of autophagy signaling in tumor microenvironment and its targeting for possible cancer therapeutics. Semin Cancer Biol. 2022;85:196\u2013208.","journal-title":"Semin Cancer Biol"},{"key":"3674_CR9","doi-asserted-by":"publisher","unstructured":"Conway JRW, Isomursu A, Follain G, H\u00e4rm\u00e4 V, Jou-Oll\u00e9 E, Pasquier N, et al. Defined extracellular matrix compositions support stiffness-insensitive cell spreading and adhesion signaling. Proc Natl Acad Sci USA. 2023; 120. https:\/\/doi.org\/10.1073\/pnas.2304288120.","DOI":"10.1073\/pnas.2304288120"},{"key":"3674_CR10","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.3390\/cancers15061899","volume":"15","author":"K Wright","year":"2023","unstructured":"Wright K, Ly T, Kriet M, Czirok A, Thomas SM. Cancer-Associated Fibroblasts: Master Tumor Microenvironment Modifiers. Cancers. 2023;15:1899.","journal-title":"Cancers"},{"key":"3674_CR11","doi-asserted-by":"publisher","unstructured":"Mai Z, Lin Y, Lin P, Zhao X, Cui L Modulating extracellular matrix stiffness: a strategic approach to boost cancer immunotherapy. Cell Death Dis. 2024; 15. https:\/\/doi.org\/10.1038\/s41419-024-06697-4.","DOI":"10.1038\/s41419-024-06697-4"},{"key":"3674_CR12","doi-asserted-by":"publisher","unstructured":"Lv D, Fei Y, Chen H, Wang J, Han W, Cui B, et al. Crosstalk between T lymphocyte and extracellular matrix in tumor microenvironment. Front Immunol. 2024; 15. https:\/\/doi.org\/10.3389\/fimmu.2024.1340702.","DOI":"10.3389\/fimmu.2024.1340702"},{"key":"3674_CR13","doi-asserted-by":"publisher","first-page":"287","DOI":"10.5483\/BMBRep.2023-0031","volume":"56","author":"O-H Kim","year":"2023","unstructured":"Kim O-H, Jeon TJ, Shin YK, Lee HJ. Role of extrinsic physical cues in cancer progression. BMB Rep. 2023;56:287\u201395.","journal-title":"BMB Rep"},{"key":"3674_CR14","doi-asserted-by":"publisher","unstructured":"Mancini A, Gentile MT, Pentimalli F, Cortellino S, Grieco M, Giordano a multiple aspects of matrix stiffness in cancer progression. Front Oncol. 2024; 14. https:\/\/doi.org\/10.3389\/fonc.2024.1406644.","DOI":"10.3389\/fonc.2024.1406644"},{"key":"3674_CR15","doi-asserted-by":"publisher","first-page":"3729","DOI":"10.1021\/acsbiomaterials.0c01530","volume":"9","author":"A Micalet","year":"2021","unstructured":"Micalet A, Moeendarbary E, Cheema U. 3D In Vitro Models for Investigating the Role of Stiffness in Cancer Invasion. ACS Biomater Sci Eng. 2021;9:3729\u201341.","journal-title":"ACS Biomater Sci Eng"},{"key":"3674_CR16","doi-asserted-by":"publisher","unstructured":"Bae YH, Mui KL, Hsu BY, Liu S-L, Cretu A, Razinia Z, et al. A FAK-Cas-Rac-Lamellipodin Signaling Module Transduces Extracellular Matrix Stiffness into Mechanosensitive Cell Cycling Sci Signal. 2014; 7. https:\/\/doi.org\/10.1126\/scisignal.2004838.","DOI":"10.1126\/scisignal.2004838"},{"key":"3674_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101170","volume":"4","author":"AM Roy","year":"2023","unstructured":"Roy AM, Iyer R, Chakraborty S. The extracellular matrix in hepatocellular carcinoma: Mechanisms and therapeutic vulnerability. Cell Rep Med. 2023;4:101170.","journal-title":"Cell Rep Med"},{"key":"3674_CR18","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1083\/jcb.201102147","volume":"196","author":"P Lu","year":"2012","unstructured":"Lu P, Weaver VM, Werb Z. The extracellular matrix: A dynamic niche in cancer progression. J Cell Biol. 2012;196:395\u2013406.","journal-title":"J Cell Biol"},{"key":"3674_CR19","doi-asserted-by":"publisher","unstructured":"Jiang Y, Zhang H, Wang J, Liu Y, Luo T, Hua H Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy. J Hematol Oncol. 2022; 15. https:\/\/doi.org\/10.1186\/s13045-022-01252-0.","DOI":"10.1186\/s13045-022-01252-0"},{"key":"3674_CR20","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1083\/jcb.201609037","volume":"215","author":"Z Sun","year":"2016","unstructured":"Sun Z, Guo SS, F\u00e4ssler R. Integrin-mediated mechanotransduction. J Cell Biol. 2016;215:445\u201356.","journal-title":"J Cell Biol"},{"key":"3674_CR21","doi-asserted-by":"publisher","unstructured":"Pang X, He X, Qiu Z, Zhang H, Xie R, Liu Z, et al. Targeting integrin pathways: mechanisms and advances in therapy. Sig Transduct Target Ther. 2023; 8. https:\/\/doi.org\/10.1038\/s41392-022-01259-6.","DOI":"10.1038\/s41392-022-01259-6"},{"key":"3674_CR22","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/nrm1490","volume":"5","author":"W Guo","year":"2004","unstructured":"Guo W, Giancotti FG. Integrin signalling during tumour progression. Nat Rev Mol Cell Biol. 2004;5:816\u201326.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3674_CR23","doi-asserted-by":"publisher","first-page":"108458","DOI":"10.1016\/j.pharmthera.2023.108458","volume":"247","author":"F Liu","year":"2023","unstructured":"Liu F, Wu Q, Dong Z, Liu K. Integrins in cancer: Emerging mechanisms and therapeutic opportunities. Pharmacol Ther. 2023;247:108458.","journal-title":"Pharmacol Ther"},{"key":"3674_CR24","doi-asserted-by":"publisher","unstructured":"Zhao X, Liu C, He X, Wang M, Zhang H, Cheng J, et al. Laminin-bound integrin \u03b16\u03b24 promotes non-small cell lung cancer progression via the activation of YAP\/TAZ signaling pathway. Front Oncol. 2022; 12. https:\/\/doi.org\/10.3389\/fonc.2022.1015709.","DOI":"10.3389\/fonc.2022.1015709"},{"key":"3674_CR25","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1038\/labinvest.2015.82","volume":"95","author":"RL Stewart","year":"2015","unstructured":"Stewart RL, O\u2019Connor KL. Clinical significance of the integrin \u03b16\u03b24 in human malignancies. Lab Investig. 2015;95:976\u201386.","journal-title":"Lab Investig"},{"key":"3674_CR26","doi-asserted-by":"publisher","first-page":"6255","DOI":"10.1039\/C6CS00052E","volume":"46","author":"Q Huang","year":"2017","unstructured":"Huang Q, Zou Y, Arno MC, Chen S, Wang T, Gao J, et al. Hydrogel scaffolds for differentiation of adipose-derived stem cells. Chem Soc Rev. 2017;46:6255\u201375.","journal-title":"Chem Soc Rev"},{"key":"3674_CR27","doi-asserted-by":"publisher","unstructured":"Zhong Y, Yu F, Yang L, Wang Y, Liu L, Jia C, et al. HOXD9\/miR-451a\/PSMB8 axis is implicated in the regulation of cell proliferation and metastasis via PI3K\/AKT signaling pathway in human anaplastic thyroid carcinoma. J Transl Med. 2023;21. https:\/\/doi.org\/10.1186\/s12967-023-04538-0.","DOI":"10.1186\/s12967-023-04538-0"},{"key":"3674_CR28","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41591-019-0750-6","volume":"26","author":"AM Laughney","year":"2020","unstructured":"Laughney AM, Hu J, Campbell NR, Bakhoum SF, Setty M, Lavall\u00e9e V-P, et al. Regenerative lineages and immune-mediated pruning in lung cancer metastasis. Nat Med. 2020;26:259\u201369.","journal-title":"Nat Med"},{"key":"3674_CR29","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ccr.2005.08.010","volume":"8","author":"MJ Paszek","year":"2005","unstructured":"Paszek MJ, Zahir N, Johnson KR, Lakins JN, Rozenberg GI, Gefen A, et al. Tensional homeostasis and the malignant phenotype. Cancer Cell. 2005;8:241\u201354.","journal-title":"Cancer Cell"},{"key":"3674_CR30","doi-asserted-by":"publisher","unstructured":"Mokhtari RB, Sampath D, Eversole P, Yu Lin MO, Bosykh DA, Boopathy GTK, et al. An Agrin\u2013YAP\/TAZ Rigidity Sensing Module Drives EGFR-Addicted Lung Tumorigenesis. Advanced Science. 2025; 12. https:\/\/doi.org\/10.1002\/advs.202413443.","DOI":"10.1002\/advs.202413443"},{"key":"3674_CR31","doi-asserted-by":"publisher","unstructured":"Pan Z, Xu T, Bao L, Hu X, Jin T, Chen J, et al. CREB3L1 promotes tumor growth and metastasis of anaplastic thyroid carcinoma by remodeling the tumor microenvironment. Mol Cancer. 2022; 21. https:\/\/doi.org\/10.1186\/s12943-022-01658-x.","DOI":"10.1186\/s12943-022-01658-x"},{"key":"3674_CR32","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.3390\/biomedicines12061286","volume":"12","author":"K Sekihara","year":"2024","unstructured":"Sekihara K, Himuro H, Toda S, Saito N, Hirayama R, Suganuma N, et al. Recent Trends and Potential of Radiotherapy in the Treatment of Anaplastic Thyroid Cancer. Biomedicines. 2024;12:1286.","journal-title":"Biomedicines"},{"key":"3674_CR33","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1158\/2159-8290.CD-24-0002","volume":"14","author":"J Prakash","year":"2024","unstructured":"Prakash J, Shaked Y. The Interplay between Extracellular Matrix Remodeling and Cancer Therapeutics. Cancer Discov. 2024;14:1375\u201388.","journal-title":"Cancer Discov"},{"key":"3674_CR34","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.3390\/cells12172126","volume":"12","author":"C-C Tsai","year":"2023","unstructured":"Tsai C-C, Yang Y-CSH, Chen Y-F, Huang L-Y, Yang Y-N, Lee S-Y, et al. Integrins and Actions of Androgen in Breast Cancer. Cells. 2023;12:2126.","journal-title":"Cells"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03674-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03674-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03674-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T09:55:48Z","timestamp":1770112548000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03674-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,2,24]]}},"alternative-id":["3674"],"URL":"https:\/\/doi.org\/10.1038\/s41388-025-03674-9","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,28]]},"assertion":[{"value":"2 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declares no competing interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animal experiments were approved by the Animal Ethics Committee of the First Hospital of Jilin University (No. 20240225-03).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}}]}}